Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-23

FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA granted a supplemental approval for Dexedrine Spansule (dextroamphetamine sulfate) to Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXEDRINE SPANSULE (Dextroamphetamine sulfate)

Snippet

SUPPL AP for DEXEDRINE SPANSULE (DEXTROAMPHETAMINE SULFATE)